Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
1.52
Funders
Boehringer Ingelheim
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Early nintedanib deployment in COVID-19 interstitial lung disease (ENDCOV-I): study protocol of a randomised, double-blind, placebo-controlled trial
Nicole Ng, María Padilla, Jigna Zatakia, Amy L. Olson et al.
Citations
1 citations
Journal
BMJ Open Respiratory Research
Topics
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Field-Weighted Citation Impact (FWCI)
1.52
article
Early nintedanib deployment in COVID-19 interstitial lung disease (ENDCOV-I): study protocol of a randomised, double-blind, placebo-controlled trial
Nicole Ng, María Padilla, Jigna Zatakia, Amy L. Olson, Aditi Mathur, Iván O. Rosas, Peide Li, Stacey-Ann Whittaker Brown, Valeria Santibañez, Michele Cohen, Nina Patel, Emilia Bagiella
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ Open Respiratory ResearchVol. 12(1)
Institutions
Hackensack University Medical Center (US), Johns Hopkins University (US), Baylor College of Medicine (US), Johns Hopkins Medicine (US), Hackensack Meridian Health (US), Boehringer Ingelheim (United States) (US), Icahn School of Medicine at Mount Sinai (US)
Funders
Boehringer Ingelheim
Sustainable Development Goals
Good health and well-being
OpenAlex Percentile
Openalex Percentile: Top 20%
Topics
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Early nintedanib deployment in COVID-19 interstitial lung disease (ENDCOV-I): study protocol of a randomised, double-blind, placebo-controlled trial — Nicole Ng, María Padilla, et al. · BMJ Open Respiratory Research (2025) | TGRS Research Map | TGRS